PL2416777T3 - Terapeutyczne zastosowania pochodnych chinazolinodionu w układzie sercowo-naczyniowym - Google Patents

Terapeutyczne zastosowania pochodnych chinazolinodionu w układzie sercowo-naczyniowym

Info

Publication number: PL2416777T3
Authority: PL; Poland
Prior art keywords: therapeutic applications; cardiovascular field; quinazolinedione derivatives; quinazolinedione; derivatives
Prior art date: 2009-04-09

Application number

PL10723222T

Other languages

English (en)

Inventor

Philip Janiak

Gilbert Marciniak

Jean-François Nave

Fabrice Viviani

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-04-09

Filing date

2010-04-07

Publication date

2015-05-29

2010-04-07 Application filed by Sanofi Sa filed Critical Sanofi Sa

2015-05-29 Publication of PL2416777T3 publication Critical patent/PL2416777T3/pl

Links

230000002526 effect on cardiovascular system Effects 0.000 title 1
150000008515 quinazolinediones Chemical class 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL10723222T 2009-04-09 2010-04-07 Terapeutyczne zastosowania pochodnych chinazolinodionu w układzie sercowo-naczyniowym PL2416777T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0901755A FR2944206B1 (fr)	2009-04-09	2009-04-09	Applications therapeutiques dans le domaine cardiovasculaire de derives de quinazolinedione
EP10723222.5A EP2416777B1 (fr)	2009-04-09	2010-04-07	Applications thérapeutiques dans le domaine cardiovasculaire de dérivés de quinazolinedione
PCT/FR2010/050672 WO2010116090A1 (fr)	2009-04-09	2010-04-07	Applications thérapeutiques dans le domaine cardiovasculaire de dérivés de quinazolinedione

Publications (1)

Publication Number	Publication Date
PL2416777T3 true PL2416777T3 (pl)	2015-05-29

Family

ID=41181038

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL10723222T PL2416777T3 (pl)	2009-04-09	2010-04-07	Terapeutyczne zastosowania pochodnych chinazolinodionu w układzie sercowo-naczyniowym

Country Status (34)

Country	Link
US (1)	US8846654B2 (pl)
EP (1)	EP2416777B1 (pl)
JP (1)	JP5685578B2 (pl)
KR (1)	KR101686267B1 (pl)
CN (1)	CN102458409B (pl)
AR (1)	AR076232A1 (pl)
AU (1)	AU2010233596B2 (pl)
BR (1)	BRPI1010256A2 (pl)
CA (1)	CA2758234A1 (pl)
CL (1)	CL2011002525A1 (pl)
CO (1)	CO6440577A2 (pl)
CR (1)	CR20110527A (pl)
CY (1)	CY1115987T1 (pl)
DK (1)	DK2416777T3 (pl)
DO (1)	DOP2011000306A (pl)
EA (1)	EA020984B1 (pl)
EC (1)	ECSP11011377A (pl)
ES (1)	ES2528633T3 (pl)
FR (1)	FR2944206B1 (pl)
HR (1)	HRP20150106T1 (pl)
HU (1)	HUE024161T2 (pl)
IL (1)	IL215610A (pl)
MA (1)	MA33254B1 (pl)
MX (1)	MX2011010645A (pl)
NI (1)	NI201100180A (pl)
NZ (1)	NZ595660A (pl)
PL (1)	PL2416777T3 (pl)
PT (1)	PT2416777E (pl)
SG (2)	SG10201400420PA (pl)
SI (1)	SI2416777T1 (pl)
TN (1)	TN2011000506A1 (pl)
TW (1)	TWI457330B (pl)
UY (1)	UY32555A (pl)
WO (1)	WO2010116090A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2944282B1 (fr) *	2009-04-09	2013-05-03	Sanofi Aventis	Derives de quinazolinedione, leur preparation et leurs diverses applications therapeutiques
US9499496B2 (en)	2012-06-05	2016-11-22	University Of Kansas	Inhibitors of respiratory syncytial virus
WO2014102589A1 (en)	2012-12-27	2014-07-03	Purdue Pharma L.P.	Quinazolin-4(3h)-one-type piperidine compounds and uses thereof
US20240208923A1 (en)	2021-03-10	2024-06-27	Jnana Therapeutics Inc.	Small molecule inhibitors of mammalian slc6a19 function
AU2023326563A1 (en)	2022-08-18	2025-02-27	Mitodicure Gmbh	Use of a therapeutic agent with phosphodiesterase-7 inhibitory activity for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance
WO2024259100A2 (en) *	2023-06-14	2024-12-19	Jnana Therapeutics Inc.	Piperidine inhibitor of slc6a19 function
US12258345B1 (en)	2023-12-12	2025-03-25	King Faisal University	Pyrrolo[3,2-c]isoquinoline-2,3-dione compounds as CK2 inhibitors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3879393A (en) *	1973-06-18	1975-04-22	Miles Lab	Derivatives of 1,3-disubstituted 2,4(1h,3h)-quinazolinediones
JPS56164172A (en) *	1980-05-22	1981-12-17	Masayuki Ishikawa	Novel 2,4 1h,3h -quinazolinedione derivative
DE3172006D1 (en) *	1980-05-22	1985-10-03	Masayuki Ishikawa	Novel quinazoline-dione compounds, process for production thereof and pharmaceutical use thereof
EP0638567A4 (en)	1993-02-18	1995-05-10	Kyowa Hakko Kogyo Kk	ADENOSINE INHIBITORS.
WO1999054284A1 (en)	1998-04-20	1999-10-28	Fujisawa Pharmaceutical Co., Ltd.	Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
WO2001044228A2 (fr)	1999-12-14	2001-06-21	Sanofi-Synthelabo	Derives de quinazolinedione et phtalimide, leurs preparations et leurs applications en therapeutique
US20090111837A1 (en)	2005-03-01	2009-04-30	Peter Cox	Use of pde7 inhibitors for the treatment of neuropathic pain
WO2006092692A1 (en)	2005-03-01	2006-09-08	Pfizer Limited	Use of combinations of pde7 inhibitors and alpha-2-delty ligands for the treatment of neuropathic pain
US7846664B2 (en)	2005-12-07	2010-12-07	The Regents Of The University Of California	Diagnosis and treatment of chronic lymphocytic leukemia (CLL)
WO2008119057A2 (en)	2007-03-27	2008-10-02	Omeros Corporation	The use of pde7 inhibitors for the treatment of movement disorders
TW200911755A (en)	2007-04-19	2009-03-16	Astellas Pharma Inc	Bicyclic heterocyclic compounds
FR2921926B1 (fr) *	2007-10-03	2009-12-04	Sanofi Aventis	Derives de quinazolinedione,leur preparation et leurs applications therapeutiques.
FR2943673B1 (fr) *	2009-03-27	2013-03-29	Sanofi Aventis	Applications therapeutiques de derives de quinazolinedione

2009
- 2009-04-09 FR FR0901755A patent/FR2944206B1/fr not_active Expired - Fee Related
2010
- 2010-04-07 BR BRPI1010256A patent/BRPI1010256A2/pt not_active IP Right Cessation
- 2010-04-07 MA MA34322A patent/MA33254B1/fr unknown
- 2010-04-07 KR KR1020117026562A patent/KR101686267B1/ko not_active Expired - Fee Related
- 2010-04-07 DK DK10723222.5T patent/DK2416777T3/en active
- 2010-04-07 CN CN201080025111.8A patent/CN102458409B/zh not_active Expired - Fee Related
- 2010-04-07 HR HRP20150106TT patent/HRP20150106T1/hr unknown
- 2010-04-07 EA EA201171229A patent/EA020984B1/ru not_active IP Right Cessation
- 2010-04-07 AU AU2010233596A patent/AU2010233596B2/en not_active Ceased
- 2010-04-07 EP EP10723222.5A patent/EP2416777B1/fr active Active
- 2010-04-07 SG SG10201400420PA patent/SG10201400420PA/en unknown
- 2010-04-07 WO PCT/FR2010/050672 patent/WO2010116090A1/fr not_active Ceased
- 2010-04-07 NZ NZ595660A patent/NZ595660A/xx not_active IP Right Cessation
- 2010-04-07 CA CA2758234A patent/CA2758234A1/fr not_active Abandoned
- 2010-04-07 ES ES10723222.5T patent/ES2528633T3/es active Active
- 2010-04-07 MX MX2011010645A patent/MX2011010645A/es active IP Right Grant
- 2010-04-07 JP JP2012504056A patent/JP5685578B2/ja not_active Expired - Fee Related
- 2010-04-07 SG SG2011073459A patent/SG175131A1/en unknown
- 2010-04-07 PL PL10723222T patent/PL2416777T3/pl unknown
- 2010-04-07 PT PT107232225T patent/PT2416777E/pt unknown
- 2010-04-07 SI SI201030847T patent/SI2416777T1/sl unknown
- 2010-04-07 HU HUE10723222A patent/HUE024161T2/hu unknown
- 2010-04-08 TW TW099110928A patent/TWI457330B/zh not_active IP Right Cessation
- 2010-04-08 AR ARP100101179A patent/AR076232A1/es unknown
- 2010-04-09 UY UY0001032555A patent/UY32555A/es not_active Application Discontinuation
2011
- 2011-10-06 EC EC2011011377A patent/ECSP11011377A/es unknown
- 2011-10-06 CR CR20110527A patent/CR20110527A/es unknown
- 2011-10-06 IL IL215610A patent/IL215610A/en not_active IP Right Cessation
- 2011-10-06 NI NI201100180A patent/NI201100180A/es unknown
- 2011-10-06 DO DO2011000306A patent/DOP2011000306A/es unknown
- 2011-10-07 TN TNP2011000506A patent/TN2011000506A1/fr unknown
- 2011-10-07 US US13/268,371 patent/US8846654B2/en not_active Expired - Fee Related
- 2011-10-07 CO CO11132796A patent/CO6440577A2/es not_active Application Discontinuation
- 2011-10-07 CL CL2011002525A patent/CL2011002525A1/es unknown
2015
- 2015-02-12 CY CY20151100141T patent/CY1115987T1/el unknown

Also Published As

Publication number	Publication date
HRP20150106T1 (hr)	2015-05-08
AU2010233596A1 (en)	2011-11-03
SI2416777T1 (sl)	2015-02-27
DOP2011000306A (es)	2011-10-31
HK1165997A1 (en)	2012-10-19
TW201040155A (en)	2010-11-16
IL215610A0 (en)	2011-12-29
JP2012523398A (ja)	2012-10-04
KR20120005499A (ko)	2012-01-16
SG10201400420PA (en)	2014-05-29
TWI457330B (zh)	2014-10-21
KR101686267B1 (ko)	2016-12-13
SG175131A1 (en)	2011-11-28
EA201171229A1 (ru)	2012-12-28
PT2416777E (pt)	2015-02-04
IL215610A (en)	2013-07-31
UY32555A (es)	2010-11-30
CN102458409B (zh)	2014-06-18
CA2758234A1 (fr)	2010-10-14
NI201100180A (es)	2012-01-11
WO2010116090A1 (fr)	2010-10-14
AR076232A1 (es)	2011-05-26
BRPI1010256A2 (pt)	2016-03-22
MA33254B1 (fr)	2012-05-02
HUE024161T2 (hu)	2016-02-29
ES2528633T3 (es)	2015-02-11
CO6440577A2 (es)	2012-05-15
DK2416777T3 (en)	2015-02-09
ECSP11011377A (es)	2011-11-30
NZ595660A (en)	2013-03-28
US20120184522A1 (en)	2012-07-19
EA020984B1 (ru)	2015-03-31
CN102458409A (zh)	2012-05-16
AU2010233596B2 (en)	2016-06-23
MX2011010645A (es)	2012-01-19
EP2416777A1 (fr)	2012-02-15
CY1115987T1 (el)	2017-01-25
US8846654B2 (en)	2014-09-30
FR2944206B1 (fr)	2012-12-28
EP2416777B1 (fr)	2014-11-12
TN2011000506A1 (fr)	2013-05-24
JP5685578B2 (ja)	2015-03-18
CL2011002525A1 (es)	2012-02-17
FR2944206A1 (fr)	2010-10-15
CR20110527A (es)	2014-05-12

Publication	Publication Date	Title
EP2440050A4 (en)	2013-04-03	TRIAZINE DERIVATIVES AND THEIR THERAPEUTIC APPLICATION
EP2440051A4 (en)	2012-12-19	TRIAZINE DERIVATIVES AND THEIR THERAPEUTIC APPLICATIONS
GB2478595B (en)	2018-04-04	Phytocannabinoids in the treatment of glioma
EP2440056A4 (en)	2012-12-05	DERIVATIVES OF UREIDOPHENYL SUBSTITUTED TRIAZINE AND THERAPEUTIC APPLICATIONS THEREOF
ZA201109034B (en)	2013-02-27	Aminopyrrolidinone derivatives and uses thereof
IL211042A0 (en)	2011-04-28	Imidazopyridin-2-one derivatives and uses thereof
ZA201103635B (en)	2012-10-31	Azaquinolinone derivatives and uses thereof
EP2440052A4 (en)	2013-01-23	TRIAZINE DERIVATIVES AND THERAPEUTIC APPLICATIONS THEREOF
IL218212A0 (en)	2012-04-30	Therapeutic methods and compositions
ZA201107009B (en)	2012-11-28	Therapeutic uses of quinazolinedione derivatives
EP2440053A4 (en)	2012-10-31	BENZYL SUBSTITUTED TRIAZINE DERIVATIVES AND THERAPEUTIC APPLICATIONS THEREOF
IL215610A0 (en)	2011-12-29	Therapeutic applications in the cardiovascular field of quinazolinedione derivatives
IL212672A (en)	2016-10-31	Cycloandesdepsipeptide compounds and their use in drug production
PH12012500555A1 (en)	2012-10-22	Spirolactam derivatives and uses of same
ZA201107363B (en)	2012-12-27	Quinazolinedione derivatives,preparation thereof and various therapeutic uses thereof
ZA201108458B (en)	2012-07-25	Nitrile derivatives and their pharmaceutical use and compositions
GB201211237D0 (en)	2012-08-08	CDK5 inhibitors and therapeutic uses thereof
IL216831A (en)	2017-03-30	History of triazine and their medical applications
SI2491005T1 (sl)	2014-12-31	Uporaba 4-(etil(dimetil)amonio)butanoata pri zdravljenju bolezni srca in oĺ˝ilja
EP2461870A4 (en)	2013-04-17	THERAPEUTIC COMPOSITIONS AND METHOD
ZA201203286B (en)	2013-07-31	Therapeutic and diagnostic applications against trypanosomosis
IL206951A0 (en)	2010-12-30	3-alkyl-piperazine derivatives and uses thereof
GB0920650D0 (en)	2010-01-13	The medicinal uses of molecules and their derivatives
PL388613A1 (pl)	2010-01-18	Nowa 7-O-n-pentylo-5-O-metylo-8-prenylonaringenina oraz sposób jej otrzymywania
GB0906043D0 (en)	2009-05-20	Nalmefene compositions and their therapeutic use